AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Biotechnology

Healthcare
$5.82 +2.48%

+$0.25 today

Market cap
$286.62M
Beta
2.62
P/E (TTM)
-7.1
EPS (TTM)
-$1.28
52W Low $8.75High $17.45

Volume 0.13M

Average 0.14M

AGMB Total Current Liabilities

All obligations due within one year.

AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB

Total Current Liabilities · Q3 FY2025 · quarter ended Sep 2025

Total current liabilities of €9.51M in Q3 FY2025

Q3 FY2025 total current liabilities was €9.51M.

Context

  • Total current liabilities amounted to 5.7% of total assets at the end of Q3 FY2025.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2025
€9.51M— QoQ
Total Current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Total Current Liabilities history

Currency unavailable · from the balance sheet

No Total Current Liabilities data reported for this period type.

Total Current Liabilities vs competitors

How AGMB compares with its peers on the latest reported figures

  • Peers report in different currencies, so total current liabilities is compared through growth and share of total assets rather than absolute size.
  • Total current liabilities amounts to 5.7% of total assets for AGMB, versus a peer median of 13.1%.
AGMB Competitors
Total Current Liabilities for AGMB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ALMSAlumis Inc. Common StockJun 2026$76.23M USD-10.9%+76.4%13.6%
ANABAnaptysBio, Inc.Mar 2026$41.7M USD-5.3%+14.0%12.6%
ACRSAclaris Therapeutics, Inc.Mar 2026$27.37M USD+27.2%+9.3%13.8%
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€9.51M EUR——5.7%
EQEquillium, Inc.Mar 2026$3.35M USD-44.3%-54.9%5.3%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding AGMB) —-8.1%+11.7%13.1%

Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Intrinsic Alpha fair value

Locked

Current Price

$5.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.